These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29516889)

  • 21. Genetic correlates of clarithromycin susceptibility among isolates of the Mycobacterium abscessus group and the potential clinical applicability of a PCR-based analysis of erm(41).
    Carvalho NFG; Pavan F; Sato DN; Leite CQF; Arbeit RD; Chimara E
    J Antimicrob Chemother; 2018 Apr; 73(4):862-866. PubMed ID: 29272470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further isolation of Mycobacterium abscessus subsp. abscessus and subsp. bolletii in different regions of Japan and susceptibility of these isolates to antimicrobial agents.
    Yoshida S; Tsuyuguchi K; Suzuki K; Tomita M; Okada M; Hayashi S; Iwamoto T; Saito H
    Int J Antimicrob Agents; 2013 Sep; 42(3):226-31. PubMed ID: 23850022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary Mycobacterium abscessus Subspecies abscessus Disease That Showed a Discrepancy Between the Genotype and Phenotype of Clarithromycin Resistance.
    Yamaba Y; Takakuwa O; Saito M; Kawae D; Yoshihara M; Mori Y; Kunii E; Ito Y; Yoshida S; Akita K
    Intern Med; 2019 Sep; 58(18):2675-2678. PubMed ID: 31178483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinico-microbiological analysis of 121 patients with pulmonary Mycobacteroides abscessus complex disease in Japan - An NTM-JRC study with RIT.
    Morimoto K; Nakagawa T; Asami T; Morino E; Fujiwara H; Hase I; Tsujimoto Y; Izumi K; Hayashi Y; Matsuda S; Murase Y; Yano R; Takasaki J; Betsuyaku T; Aono A; Goto H; Nishimura T; Sasaki Y; Hoshino Y; Kurashima A; Ato M; Ogawa K; Hasegawa N; Mitarai S
    Respir Med; 2018 Dec; 145():14-20. PubMed ID: 30509703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.
    Jeon K; Kwon OJ; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Koh WJ
    Am J Respir Crit Care Med; 2009 Nov; 180(9):896-902. PubMed ID: 19661243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Intensified Regimen Containing Linezolid Could Improve Treatment Response in
    Li H; Tong L; Wang J; Liang Q; Zhang Y; Chu N; Chen X; Duan H
    Biomed Res Int; 2019; 2019():8631563. PubMed ID: 31828137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series.
    Namkoong H; Morimoto K; Nishimura T; Tanaka H; Sugiura H; Yamada Y; Kurosaki A; Asakura T; Suzuki S; Fujiwara H; Yagi K; Ishii M; Tasaka S; Betsuyaku T; Hoshino Y; Kurashima A; Hasegawa N
    BMC Infect Dis; 2016 Aug; 16():396. PubMed ID: 27506679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Clarithromycin Susceptibility Genotype Affects the Treatment Outcome of Patients with Mycobacterium abscessus Lung Disease.
    Guo Q; Chu H; Ye M; Zhang Z; Li B; Yang S; Ma W; Yu F
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483126
    [No Abstract]   [Full Text] [Related]  

  • 29. Outcomes of pulmonary
    Flight WG; Hough NE; Chapman SJ
    Int J Mycobacteriol; 2020; 9(1):48-52. PubMed ID: 32474488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41).
    Maurer FP; Rüegger V; Ritter C; Bloemberg GV; Böttger EC
    J Antimicrob Chemother; 2012 Nov; 67(11):2606-11. PubMed ID: 22833642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimycobacterial activity of veterinary antibiotics (Apramycin and Framycetin) against
    Moore JE; Koulianos G; Hardy M; Misawa N; Millar BC
    Int J Mycobacteriol; 2018; 7(3):265-267. PubMed ID: 30198508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy.
    Kim HS; Lee KS; Koh WJ; Jeon K; Lee EJ; Kang H; Ahn J
    Radiology; 2012 Apr; 263(1):260-70. PubMed ID: 22371609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus.
    Li B; Ye M; Guo Q; Zhang Z; Yang S; Ma W; Yu F; Chu H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease.
    Siegel SAR; Griffith DE; Philley JV; Brown-Elliott BA; Brunton AE; Sullivan PE; Fuss C; Strnad L; Wallace RJ; Winthrop KL
    Chest; 2023 Oct; 164(4):846-859. PubMed ID: 37419144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of the antimicrobial susceptibility and molecular profile of clarithromycin resistance in the Mycobacterium abscessus complex in Japan by variable number tandem repeat analysis.
    Kusuki M; Osawa K; Arikawa K; Tamura M; Shigemura K; Shirakawa T; Nakamura T; Nakamachi Y; Fujisawa M; Saegusa J; Tokimatsu I
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):256-259. PubMed ID: 29550059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence.
    Pasipanodya JG; Ogbonna D; Ferro BE; Magombedze G; Srivastava S; Deshpande D; Gumbo T
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs.
    Brown-Elliott BA; Vasireddy S; Vasireddy R; Iakhiaeva E; Howard ST; Nash K; Parodi N; Strong A; Gee M; Smith T; Wallace RJ
    J Clin Microbiol; 2015 Apr; 53(4):1211-5. PubMed ID: 25653399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial Susceptibility and Phylogenetic Relations in a German Cohort Infected with Mycobacterium abscessus.
    Wetzstein N; Kohl TA; Schultze TG; Andres S; Bellinghausen C; Hügel C; Kempf VAJ; Lehn A; Hogardt M; Serve H; Vehreschild MJGT; Wolf T; Niemann S; Maurer FP; Wichelhaus TA
    J Clin Microbiol; 2020 Nov; 58(12):. PubMed ID: 32938741
    [No Abstract]   [Full Text] [Related]  

  • 40. Current significance of the Mycobacterium chelonae-abscessus group.
    Jones RS; Shier KL; Master RN; Bao JR; Clark RB
    Diagn Microbiol Infect Dis; 2019 Jul; 94(3):248-254. PubMed ID: 30954313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.